New Delhi: Scientists are exploring innovative ways to make older antibiotics effective again as the global threat of antimicrobial resistance (AMR) continues to rise, posing a serious challenge to modern medicine.
According to recent research highlighted in The Indian Express, antibiotic resistance has rendered many commonly used drugs ineffective, prompting experts to revisit older antibiotics and enhance their performance through new techniques rather than relying solely on the development of new drugs.
Renewed focus on old antibiotics
With the antibiotic development pipeline slowing down and very few new drug classes emerging in recent decades, researchers are now focusing on reviving older antibiotics. These drugs, once sidelined due to resistance or side effects, are being re-evaluated using advanced scientific approaches to restore their effectiveness.
New strategies to boost effectiveness
Experts suggest multiple approaches to make older antibiotics work again. One key method involves combining antibiotics with other compounds that can block bacterial resistance mechanisms, allowing the drugs to function effectively.
Another promising strategy includes using technologies such as nanoparticles or targeted drug delivery systems to improve how antibiotics reach and act on infection sites. Scientists are also studying ways to disrupt bacterial defence systems, making them more vulnerable to existing medicines.
Growing concern over antibiotic resistance
AMR has emerged as a major public health crisis globally and in India. Overuse and misuse of antibiotics—such as taking them for viral infections or without proper prescriptions—have accelerated the development of resistant bacteria.
Health experts warn that this trend could make common infections harder to treat and increase the risk associated with routine medical procedures.
Importance of responsible antibiotic use
Doctors emphasise that reviving old antibiotics alone will not solve the problem unless antibiotic use is regulated. Responsible prescribing, completing prescribed courses, and avoiding unnecessary consumption are critical steps in slowing resistance.
Way forward
Researchers and policymakers agree that a combined approach is needed—reviving older drugs, investing in new antibiotic development, and improving public awareness about proper usage. Without coordinated action, experts caution that the world may face a future where even minor infections become life-threatening.